News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
News Conference News TCT 2025 iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI Yael L. Maxwell October 28, 2025
News Conference News TCT 2025 PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats Todd Neale October 28, 2025
News Conference News TCT 2025 LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI L.A. McKeown October 27, 2025
News Conference News TCT 2025 Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions Todd Neale October 26, 2025
News Conference News ESC 2025 Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD L.A. McKeown September 05, 2025
News Conference News EuroPCR 2025 Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS L.A. McKeown May 30, 2025
News Conference News EuroPCR 2025 Early Coronary Function Testing Improves Quality of Life in ANOCA Yael L. Maxwell May 28, 2025
News Conference News EuroPCR 2025 IVL Effective in Severely Calcified Lesions, Especially in Women Yael L. Maxwell May 22, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Conference News CX Symposium 2025 Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI L.A. McKeown April 30, 2025
News Conference News CX Symposium 2025 Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK L.A. McKeown April 24, 2025
News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices L.A. McKeown April 23, 2025
News Conference News ACC 2025 AI Shows Promise in Detecting Type 1 MI and Need for Revascularization Yael L. Maxwell April 07, 2025
News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Conference News VIVA 2024 DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years L.A. McKeown November 11, 2024
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
News Conference News TCT 2024 PAD Patients’ Views on Decisions and Outcomes Hinge on Sex, Race/Ethnicity: ELEGANCE L.A. McKeown November 04, 2024
News Conference News TCT 2024 CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events Yael L. Maxwell November 01, 2024